Alan R. Ellis

Alan R. Ellis

Auto-generated profile, based on publicly available information

Alan R. Ellis

School of Social Work North Carolina State University Raleigh North Carolina USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2018 in PharmacoEconomics
Verified
Journal Article
Open access
PDF file
VSVikas Soekhai
Vikas Soekhai
EBEsther W. de Bekker-Grob
Esther W. de Bekker-Grob
AEAlan R. Ellis
Alan R. Ellis
CVCaroline M. Vass
Caroline M. Vass
Objectives Discrete choice experiments (DCEs) are increasingly advocated as a way to quantify preferences for health. However, increasing support does not necessarily result in increasing quality. Although specific reviews have been conducted in certain contexts, there exists no recent description of the general state of the science of health-related DCEs. The aim of this paper was to update prior reviews (1990–2012), to identify all health-related DCEs and to provide a description of trends, current practice and future challenges. Methods A systematic literature review was conducted to identify health-related empirical DCEs published between 2013 and 2017. The search strategy and data extraction replicated prior reviews to allow the reporting of trends, although additional extraction fields were incorporated. Results Of the 7877 abstracts generated, 301 studies met the inclusion criteria and underwent data extraction. In general, the total number of DCEs per year continued to increase, with broader areas of application and increased geographic scope. Studies reported using more sophisticated designs (e.g. D-efficient) with associated software (e.g. Ngene). The trend towards using more sophisticated econometric models also continued. However, many studies presented sophisticated methods with insufficient detail. Qualitative research methods continued to be a popular approach for identifying attributes and levels. Conclusions The use of empirical DCEs in health economics continues to grow. However, inadequate reporting of methodological details inhibits quality assessment. This may reduce decision-makers’ confidence in results and their ability to act on the findings. How and when to integrate health-related DCE outcomes into decision-making remains an important area for future research.

4 December 2019 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
TOTetsu Ohnuma
Tetsu Ohnuma
KRKarthik Raghunathan
Karthik Raghunathan
SMSean Moore
Sean Moore
SSSoko Setoguchi
Soko Setoguchi
AEAlan R. Ellis
Alan R. Ellis
VKVijay Krishnamoorthy
Vijay Krishnamoorthy
Background: Gabapentinoids are commonly prescribed in perioperative multimodal analgesia protocols. Despite widespread use, the optimal dose to reduce opioid consumption while minimizing risks is unknown. We assessed dose-dependent effects of gabapentinoids on opioid consumption and postoperative pulmonary complications following total hip or knee arthroplasty (THA or TKA). We hypothesized that use of a gabapentinoid on the day of THA or TKA is associated with an increased risk of postoperative pulmonary complications in a dose-response fashion compared with the risk for patients who did not receive the drug. Methods: Using the Premier Database, we identified adults who underwent elective primary THA or TKA from 2009 to 2014. The exposure was receipt of a gabapentinoid (gabapentin or pregabalin) on the day of surgery. Gabapentin dose was categorized into 5 groups: none, 1 to 350, 351 to 700, 701 to 1,050, and >1,050 mg per day. Pregabalin dose was categorized into 4 groups: none, 1 to 110, 111 to 250, and >250 mg per day. The primary outcome was a composite of postoperative pulmonary complications, defined as respiratory failure, pneumonia, reintubation, pulmonary edema, noninvasive ventilation, or invasive mechanical ventilation. Results: Of 858,306 patients who underwent THA or TKA, 11.0% received gabapentin and 10.2% received pregabalin. The mean age (and standard deviation) of the patients was 65.6 ± 10.7 years, 39.6% were male, 78.2% were Caucasian, and 55.2% were covered by Medicare. In multilevel regression analysis, receipt of gabapentinoid at any dose on the day of surgery was associated with increased odds of postoperative pulmonary complications. Compared with no exposure to the drug being used by the particular group, all dose ranges of gabapentin and pregabalin were associated with greater odds of postoperative pulmonary complications (odds ratio, 95% confidence interval = 1.51, 1.40 to 1.63, for >1,050 mg of gabapentin and 1.81, 1.57 to 2.09, for >250 mg of pregabalin). We found no clinically meaningful associations between exposure to either gabapentin or pregabalin and perioperative opioid consumption or the length of the hospital stay. Conclusions: Exposure to gabapentinoids at any dose on the day of THA or TKA was associated with increased odds of postoperative pulmonary complications in a dose-response fashion, with minimal effects on perioperative opioid consumption. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

23 February 2021 in Statistics in Medicine
Verified
Journal Article
Closed access
PDF file
MCMitchell M. Conover
Mitchell M. Conover
KRKenneth J. Rothman
Kenneth J. Rothman
TSTil Stürmer
Til Stürmer
AEAlan R. Ellis
Alan R. Ellis
CPCharles Poole
Charles Poole
MFMichele Jonsson Funk
Michele Jonsson Funk

18 February 2021 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
TOTetsu Ohnuma
Tetsu Ohnuma
KRKarthik Raghunathan
Karthik Raghunathan
MFMatthew Fuller
Matthew Fuller
AEAlan R. Ellis
Alan R. Ellis
EJEric A. JohnBull
Eric A. JohnBull
VKVijay Krishnamoorthy
Vijay Krishnamoorthy
Background: The transition to the new ICD-10 (International Classification of Diseases, Tenth Revision) coding system in the U.S. poses challenges to the ability to consistently and accurately measure trends in comorbidities and complications. We examined the prevalence of comorbidities and postoperative medical complications before and after the transition from ICD-9 to ICD-10 among patients who underwent primary total hip or knee arthroplasty (THA or TKA). We hypothesized that the transition to ICD-10 codes was associated with discontinuity and slope change in comorbidities and medical complications. Methods: The Elixhauser comorbidities and medical complications were identified using the Premier Healthcare database from fiscal year (FY)2011 to FY2018. Using multivariable segmented regression models, we examined the changes in the levels and slopes after the transition from ICD-9 to ICD-10 coding. Odds ratios (ORs) of 1 indicate decreases and increases, respectively, in levels and slopes. Results: Overall, 2,006,581 patients who underwent primary THA or TKA were identified. The mean age was 65.9 ± 10.5 years, and the median length of the hospital stay was 2 days (interquartile range [IQR], 2 to 3 days). Of the comorbidities studied, congestive heart failure, hypertension, and obesity had a statistically significant but clinically small discontinuity after the transition from ICD-9 to ICD-10 coding. Of the complications, pneumonia (OR = 0.66, 95% confidence interval [CI] = 0.48 to 0.90), acute respiratory failure (OR = 1.88, 95% CI = 1.52 to 2.33), sepsis (OR = 2.54, 95% CI = 1.45 to 4.44), and urinary tract infection (OR = 1.79, 95% CI = 1.32 to 2.42) demonstrated statistically significant discontinuity. Alcohol abuse and paralysis had an increasing prevalence before the ICD transition, followed by a decreasing prevalence after the transition. In contrast, metastatic cancer, weight loss, and acquired immunodeficiency syndrome (AIDS) showed a decreasing prevalence before the ICD transition followed by an increasing prevalence after the transition. Generally, complications showed a decreasing prevalence over time. Conclusions: The discontinuities after the transition from ICD-9 to ICD-10 coding were relatively small for most comorbidities. Medical complications generally showed a decreasing trend over the quarters studied. These findings support caution when conducting joint replacement studies that rely on ICD coding and include the ICD coding transition period.

20 April 2011 in Research on Social Work Practice
Verified
Journal Article
Closed access
MFMark W. Fraser
Mark W. Fraser
SGShenyang Guo
Shenyang Guo
AEAlan R. Ellis
Alan R. Ellis
ATAaron M. Thompson
Aaron M. Thompson
TWTraci Wike
Traci Wike
JLJilan Li
Jilan Li
This article describes the core features of outcome research and then explores issues confronting researchers who engage in outcome studies. Using an intervention research perspective, descriptive and explanatory methods are distinguished. Emphasis is placed on the counterfactual causal perspective, designing programs that fit culture and context, and developing nuanced explanations for program outcomes. Five emerging challenges are discussed: (a) adapting interventions to the contexts and cultures in which programs are to be implemented, (b) avoiding potentially false attributions of program failure due to differential implementation, (c) making causal inferences from observational data with propensity score analysis (PSA), (d) examining person-centered outcomes in program evaluation, and (e) adjusting for rater effects in longitudinal research.

30 July 2024 in Journal of Hospital Medicine
Verified
Journal Article
Closed access
RHRachel Hirshman
Rachel Hirshman
SHShavone Hamilton
Shavone Hamilton
MWMelissa Walker
Melissa Walker
AEAlan R. Ellis
Alan R. Ellis
NINoel Ivey
Noel Ivey
DCDana Clifton
Dana Clifton